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New York Medical College, Departments of Orthopedic Surgery and Pathology

BACKGROUND

MATERIALS & METHODS

Stem cells are defined as undifferentiated cells with the capacity for both
self-renewal and future differentiation. Importantly, stem cells can
proliferate while maintaining an undifferentiated state, and can differentiate
into at least one phenotype. Adult, or somatic, stem cells are maintained
throughout life to renew and repair the local tissues. There are several
different varieties of adult stem cells, which include mesenchymal stem
cells (MSCs), hematopoietic stem cells, and neural stem cells. Multipotent
adult stem cells (MASCs) are distinct from MSCs as undifferentiated cells
found in several tissues in post-natal animals. They are able to generate
progeny of several distinct cell types of all three dermal lineages, and have
an apparent unlimited proliferation potential. Their differentiation is
determined by local cues. To date, very little is known about the gene
expression profile of MASCs. Since bone marrow-derived MSCs were first
experimentally expanded and differentiated through 4 mesodermal
lineages in the 1990’s1, MSCs have been the subject of investigation due to
their relative accessibility and supposed regenerative potential. Despite the
wealth of knowledge these studies have provided, the exact nature of the
relationship between MSCs and MASCs remains to be elucidated.

RNA-seq was performed on MASCs cultured in vitro in the laboratory. MASCs were isolated
from the dermis layer of human foreskin (HfSC-2) and were tested at Passage (P) 20. We
then compared the gene expression of the MASCs to databases of genes expressed by
bone marrow-derived mesenchymal stem cells (BM-MSCs) and placenta-derived
mesenchymal stem cells (PL-MSCs)2. Significant differences were found in the relative gene
expressions of the PL-MSCs, BM-MSCs, and HfSCs. Previously published data have shown
that differences in gene expression exist even between two families of MSCs2. The NIH
Database for Annotation, Visualization and Integrated Discovery (DAVID) was used to
perform gene functional annotation clustering, with default options and annotation
categories. Specific studies of pathway enrichment were performed utilizing DAVID’s GOBG annotation (Gene Ontology- Biological Groupings)3.

PURPOSE & HYPOTHESIS
Given the differences in differentiation and reproductive potential,
we hypothesize that MASCs have a unique gene expression
profile in comparison to other adult stem cells, particularly
MSCs.

Table 1:Minimal Criteria of Mesenchymal Stem
Cells
ISCT Criteria

BM-MSC

PL-MSC

HfSC

Plastic Adherent

+
+
+
+
+
+

+
+
+
+
-

+
+
+
+
-

BM-MSC
+
-

PL-MSC
+
+
+

HfSC
+
+

CD73+
CD90+
CD105+
CD11bCD14CD19CD34CD45HLA-DR-

Other Criteria
CD106 (VCAM1)+
CD117 (KIT)CD271 (NGFR)+
CD56 (NCAM1)-

RESULTS

CONCLUSIONS
The 6 developmental pathways listed below provide clues to explain
the wide differentiation potential of MASCs; they uniquely express
genes important for the early progression of these pathways. In
addition to epiregulin, the genes involved in germline development
may provide insight into the apparent unlimited proliferation potential
of MASCs. Future studies will include a comparison of gene
expression profiles between HfSCs and human ESCs, and between
HfSCs and human differentiated cells, specifically smooth muscle
cells.
The BM-MSC mRNA expression does not conform to the ISCT
standards, or other common MSC cellular markers. That the PLMSCs do not conform to certain MSC cellular markers either,
indicates that current protein and gene expression criteria for defining
adult stem cells may be inadequate as they currently stand.

Developmental Pathways

Both HfSC and PL-MSC met the minimum criteria for MSCs (Table 1). Ironically, BM-MSC
did not. However, we have identified 507 genes that are expressed in HfSCs but not in BMMSCs or PL-MSCs, and 520 genes that were expressed in the MSC lineages but not the
HfSCs. The most notable differences among HfSCs, BM- and PL-MSCs were observed in
genes involved with neural development. All three stem cells do not express Oct-4, Sox-2,
and Nanog – genes considered critical genes for embryonic stem cells (ESCs). Those
uniquely expressed by the HfSCs included epiregulin, a gene required for sustained cell
growth without senescence; several genes for early neural development (ROBO2,
FRMPD4, PCDH9); genes associated with development of germline cells (LHX9 and
IGF2BP3); genes for early neuroectodermal development (RSPO2 and ZIC1); genes for
development of endodermal phenotypes (NKX6-1 and ONECUT1); and genes associated
with cardiac development (TBX5).

Germline
Development
LHX9, IGF2BP3
Limb Morphogenesis
WNT3, SOX11, TBX4,
TFAP2A, PTCH1, LRP4

HfSC

Number of Genes Significantly Expressed
in each Stem Cell Line
507
Cardiac
Development
TBX5

HfSC
11,402
348

344

*
BM-MSC
11,531

520

460

PL-MSC
11,419
871

Other criteria:
Ravenska Wagey. Mini-Review Mesenchymal Cells. STEMCELL Technologies Inc. www.STEMCELL.com;(2011).

Endodermal
Development
NKX6-1,
ONECUT1

Neural Development
ROBO2, FRMPD4,
PCDH9
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